Oscar Health, Inc. (NYSE:OSCR) Shares Bought by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. increased its position in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 175.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 70,806 shares of the company's stock after acquiring an additional 45,088 shares during the quarter. Oppenheimer & Co. Inc.'s holdings in Oscar Health were worth $1,502,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Point72 Hong Kong Ltd acquired a new position in shares of Oscar Health in the 2nd quarter valued at $78,000. Quest Partners LLC purchased a new position in Oscar Health in the second quarter valued at about $93,000. Amalgamated Bank raised its position in shares of Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company's stock worth $106,000 after purchasing an additional 1,458 shares during the period. Optimum Investment Advisors bought a new position in Oscar Health during the 3rd quarter valued at $142,000. Finally, Farallon Capital Management LLC purchased a new stake in shares of Oscar Health during the first quarter worth $164,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have recently issued reports on OSCR. Piper Sandler reiterated an "overweight" rating and issued a $28.00 target price on shares of Oscar Health in a research note on Tuesday, September 10th. Bank of America downgraded shares of Oscar Health from a "neutral" rating to an "underperform" rating and dropped their price target for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Finally, UBS Group started coverage on shares of Oscar Health in a report on Monday, October 7th. They set a "neutral" rating and a $23.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Oscar Health has an average rating of "Moderate Buy" and an average price target of $22.93.

Insider Buying and Selling

In related news, insider Mario Schlosser sold 3,198 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the transaction, the insider now directly owns 76,982 shares of the company's stock, valued at $1,384,906.18. This represents a 3.99 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Vice Chairman Joshua Kushner acquired 358,619 shares of the stock in a transaction that occurred on Wednesday, November 13th. The shares were bought at an average price of $13.74 per share, for a total transaction of $4,927,425.06. Following the transaction, the insider now owns 5,810,700 shares of the company's stock, valued at $79,839,018. This trade represents a 6.58 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 1,055,478 shares of company stock worth $14,432,852 and sold 169,569 shares worth $3,007,069. 25.11% of the stock is currently owned by corporate insiders.

Oscar Health Price Performance

Oscar Health stock traded up $0.78 during midday trading on Monday, reaching $15.65. 2,731,085 shares of the company were exchanged, compared to its average volume of 3,376,635. The company has a market capitalization of $3.79 billion, a price-to-earnings ratio of -247.79 and a beta of 1.67. Oscar Health, Inc. has a 1 year low of $7.29 and a 1 year high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.73. The firm's 50-day simple moving average is $18.20 and its 200-day simple moving average is $18.27.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The business had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The firm's quarterly revenue was up 68.3% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.29) earnings per share. On average, analysts anticipate that Oscar Health, Inc. will post -0.01 EPS for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.